MEDICAL DEVICE INNOVATION - Medical Device Daily

More documents

Recommendations

Info

26 TCT 2009 Carillon, MitraClip data wow standing-room crowd at TCT By MARK McCARTY Medical Device Daily Washington Editor SAN FRANCISCO – Mitral valve regurgitation has long proven a tough nut to crack, but recent data from trials for developmental devices suggests that medical science is making headway on this front. Some of the trials also suggest that the effect of these fixes on congestive heart failure is discernible, leading one of the presenters to remark that the Centers for Medicare & Medicaid Services might be happy to hear about some of these data. All the same, the FDA hurdle must be cleared first and the devices in question have not yet made that leap, although the presenters seemed optimistic on that count. Tomasz Siminiak, MD, of the Poznan University of Medical Sciences (Poznan, Poland), discussed six-month data from the Titan trial for the Carillon mitral valve contour system, made by Cardiac Dimensions (Kirkland, Washington). This device is fixed around the mitral valve and uses tension to keep it in place while the tension forces the mitral valve into a tighter circumferential geometry, hence reducing regurgitation. Unlike most percutaneous devices, the device is intended for delivery via the jugular vein. Reviewing six-month data from the Titan trial, Siminiak reminded the audience, which was a standing-room-only crowd, that the intended indication is for patients with severe regurgitation and a left ventricular ejection fraction of less than 30%. Inclusion criteria were New York Heart Association class II, III and IV heart failure and the primary safety endpoint was the 30-day rate of major adverse events (MAE). The device consists of two nitinol anchors and a bridge implanted into the coronary sinus. The distal anchor is set while the catheter withdraws so as to set the proximal anchor. The procedure can be reversed and captured by the catheter up to the point of decoupling of the catheter from the proximal anchor, so a surgeon who sees a problem with anchoring can reverse and withdraw. Siminiak noted that the Titan study enrolled 65, with 12 who flunked screening, leaving an intent-to-treat group of 53. Of this group, 36 were implanted while the other 17 MEDICAL DEVICE INNOVATION 2010 were not due to “insufficient mitral regurgitation reduction,” Siminiak said, and/or coronary artery compromise. Of the 53 ITT enrollees, 50 were in New York Heart Association class III heart failure, two were in class IV, and one in class II. Siminiak said procedural safety in Titan was excellent. “The major adverse event rate of 1.9% at 30 days highlights the safety of this procedure,” he said. Measures of regurgitation after six months showed that the narrowest point of the ejection stream had shrunk by roughly a third. “The volume of the jet was very small, very thin,” said Siminiak, and hence improvement in regurgitation was by at least one class in all cases. He also said the “significant reduction in MR was maintained after six months” and that the data indicate a “positive effect on remodeling.” The audience seemed impressed, with one attendee characterizing the data as “very promising.” As for whether any patients experienced recurrence of regurgitation, Siminiak said there was “a single patient with loss of detention” of the valve, but added that “some patients improved into reverse remodeling” of their heart failure. Siminiak remarked that the device was not exactly as originally designed. The Carillon was originally designed with two anchors made of a pair of wires each for tension, but there was originally no twist in the anchoring wires. After several early cases indicated the initial design lacked sufficient tension in the distal anchor, the company twisted those anchor wires, and the proximal anchors wires had also been twisted by the time the sponsor started enrolling for the Titan trial. Saibal Kar, MD, of Cedars Sinai Medical Center (Los Angeles), reviewed the Everest (Endovascular Valve Edgeto-Edge REpair STudy) trial for the MitraClip, which is indeed a clip that is placed about midway across the two leaves of the mitral valve, pinching that portion of the leaves together. Hence, the mitral valve is left with two smaller openings, and the device’s placement is intra-operatively adjusted for ideal ejection volume. The product is made by Evalve (Menlo Park, California). Kar observed that while “the effect of valve repair without annuloplasty” is not known, he remarked that the hypothesis is that “putting in a MitraClip might actually regress” congestive heart failure. Of the 78 subjects initially enrolled, 32 exhibited diastolic MR and the remainder functional MR. He noted that the estimated STS (Society of Thoracic Surgeons) score averaged 17%. “Most would agree To subscribe, please call MEDICAL DEVICE DAILY Customer Service at (800) 888-3912; outside the U.S. and Canada, call (404) 262-5547. Copyright © 2010 AHC Media LLC. Reproduction is strictly prohibited.
MEDICAL DEVICE INNOVATION 2010 27 this is a really sick population,” he observed. Kar said that the session marked the debut of data for annular dimensions. “For the first time we noticed what happens to the septal-lateral dimensions,” he said, noting that for the 26 patients with one-year data, diastolic annular dimension dropped from 3.8mm to 3.6 and systolic dimension fell from 3.2mm to 3.0. As for ejection fraction (EF), he said there was “expected to be no change in EF, but impressively an improvement,” from 48% to 42%. Kar also noted that the rate of rehospitalization for symptoms of heart failure among the 26 patients followed to a year was 30%. He quipped, “I’m sure Medicare would like to see this data.” Perhaps as impressive was the average regurgitation score, which dropped from 3.1 to 1.6 over 12 months. According to a Sept. 22 company statement, the Everest echo imaging data indicate “complete fibrous encapsulation of the MitraClip device with organized, endocardial tissue growth.” The statement also indicates that the device is well tolerated, with “no significant stenosis or inflammation . . . observed beyond 300 days.” (This story originally appeared in the Sept. 23, 2009, edition of Medical Device Daily) To subscribe, please call MEDICAL DEVICE DAILY Customer Service at (800) 888-3912; outside the U.S. and Canada, call (404) 262-5547. Copyright © 2010 AHC Media LLC. Reproduction is strictly prohibited.
Page 1 and 2: MEDICAL DEVICE DAILY MEDICAL DEVIC
Page 3 and 4: MEDICAL DEVICE INNOVATION 2010 1 AB
Page 5 and 6: MEDICAL DEVICE INNOVATION 2010 3 Ta
Page 7 and 8: MEDICAL DEVICE INNOVATION 2010 5 In
Page 9 and 10: MEDICAL DEVICE INNOVATION 2010 A ti
Page 11 and 12: MEDICAL DEVICE INNOVATION 2010 9 do
Page 13 and 14: MEDICAL DEVICE INNOVATION 2010 Hear
Page 15 and 16: MEDICAL DEVICE INNOVATION 2010 ARS
Page 17 and 18: MEDICAL DEVICE INNOVATION 2010 15 b
Page 19 and 20: MEDICAL DEVICE INNOVATION 2010 17 T
Page 21 and 22: MEDICAL DEVICE INNOVATION 2010 Avan
Page 23 and 24: MEDICAL DEVICE INNOVATION 2010 Body
Page 25 and 26: MEDICAL DEVICE INNOVATION 2010 Came
Page 27: MEDICAL DEVICE INNOVATION 2010 25 t
Page 31 and 32: MEDICAL DEVICE INNOVATION 2010 29 2
Page 33 and 34: MEDICAL DEVICE INNOVATION 2010 Coru
Page 35 and 36: MEDICAL DEVICE INNOVATION 2010 33 s
Page 37 and 38: MEDICAL DEVICE INNOVATION 2010 Surg
Page 39 and 40: MEDICAL DEVICE INNOVATION 2010 Chee
Page 41 and 42: MEDICAL DEVICE INNOVATION 2010 39 t
Page 43 and 44: MEDICAL DEVICE INNOVATION 2010 Cohe
Page 45 and 46: MEDICAL DEVICE INNOVATION 2010 FDA
Page 47 and 48: MEDICAL DEVICE INNOVATION 2010 45 c
Page 49 and 50: MEDICAL DEVICE INNOVATION 2010 Enfa
Page 51 and 52: MEDICAL DEVICE INNOVATION 2010 Drex
Page 53 and 54: MEDICAL DEVICE INNOVATION 2010 Ekos
Page 55 and 56: MEDICAL DEVICE INNOVATION 2010 53 I
Page 57 and 58: MEDICAL DEVICE INNOVATION 2010 55 w
Page 59 and 60: MEDICAL DEVICE INNOVATION 2010 Exmo
Page 61 and 62: MEDICAL DEVICE INNOVATION 2010 Endo
Page 63 and 64: MEDICAL DEVICE INNOVATION 2010 Broa
Page 65 and 66: MEDICAL DEVICE INNOVATION 2010 Heal
Page 67 and 68: MEDICAL DEVICE INNOVATION 2010 Stud
Page 69 and 70: MEDICAL DEVICE INNOVATION 2010 ExAb
Page 71 and 72: MEDICAL DEVICE INNOVATION 2010 69 J
Page 73 and 74: MEDICAL DEVICE INNOVATION 2010 71 c
Page 75 and 76: MEDICAL DEVICE INNOVATION 2010 Hybr
Page 77 and 78: MEDICAL DEVICE INNOVATION 2010 Tru-
Page 79 and 80:
MEDICAL DEVICE INNOVATION 2010 77 L
Page 81 and 82:
MEDICAL DEVICE INNOVATION 2010 Lumi
Page 83 and 84:
MEDICAL DEVICE INNOVATION 2010 81 t
Page 85 and 86:
MEDICAL DEVICE INNOVATION 2010 MTI
Page 87 and 88:
MEDICAL DEVICE INNOVATION 2010 Micr
Page 89 and 90:
MEDICAL DEVICE INNOVATION 2010 Nano
Page 91 and 92:
MEDICAL DEVICE INNOVATION 2010 89 s
Page 93 and 94:
MEDICAL DEVICE INNOVATION 2010 91 A
Page 95 and 96:
MEDICAL DEVICE INNOVATION 2010 93 m
Page 97 and 98:
MEDICAL DEVICE INNOVATION 2010 NiTi
Page 99 and 100:
MEDICAL DEVICE INNOVATION 2010 NMT
Page 101 and 102:
MEDICAL DEVICE INNOVATION 2010 Tran
Page 103 and 104:
MEDICAL DEVICE INNOVATION 2010 New
Page 105 and 106:
MEDICAL DEVICE INNOVATION 2010 Paci
Page 107 and 108:
MEDICAL DEVICE INNOVATION 2010 105
Page 109 and 110:
Page 111 and 112:
MEDICAL DEVICE INNOVATION 2010 Non-
Page 113 and 114:
MEDICAL DEVICE INNOVATION 2010 Pros
Page 115 and 116:
Page 117 and 118:
MEDICAL DEVICE INNOVATION 2010 Sanu
Page 119 and 120:
MEDICAL DEVICE INNOVATION 2010 Clos
Page 121 and 122:
MEDICAL DEVICE INNOVATION 2010 Once
Page 123 and 124:
MEDICAL DEVICE INNOVATION 2010 SFC
Page 125 and 126:
MEDICAL DEVICE INNOVATION 2010 Mayo
Page 127 and 128:
MEDICAL DEVICE INNOVATION 2010 C-Pu
Page 129 and 130:
MEDICAL DEVICE INNOVATION 2010 supe
Page 131 and 132:
MEDICAL DEVICE INNOVATION 2010 Syne
Page 133 and 134:
Page 135 and 136:
MEDICAL DEVICE INNOVATION 2010 Ther
Page 137 and 138:
MEDICAL DEVICE INNOVATION 2010 Gold
Page 139 and 140:
MEDICAL DEVICE INNOVATION 2010 Nano
Page 141 and 142:
Page 143 and 144:
MEDICAL DEVICE INNOVATION 2010 Pilo
Page 145 and 146:
MEDICAL DEVICE INNOVATION 2010 US E
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
MEDICAL DEVICE INNOVATION 2010 A ti
Page 153 and 154:
MEDICAL DEVICE INNOVATION 2010 VisE
Page 155 and 156:
Page 157:
show all

MEDICAL DEVICE INNOVATION - Medical Device Daily

Create successful ePaper yourself

Delete template?

Save as template?